Syndax Pharmaceuticals Inc (SNDX) financials · rev $172.4M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Syndax Pharmaceuticals Inc (SNDX) rev $172.4M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $172.4M | $23.7M |
| Operating Income | -$273.1M | -$339.7M |
| Net Income | -$285.4M | -$318.8M |
| EPS (Diluted) | -$3.29 | -$3.72 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $529.7M | $724.8M |
| Current Assets | $528.1M | $603.1M |
| Cash & Equivalents | $134.9M | $154.1M |
| Inventory | $32.8M | $366.0K |
| PP&E | $181.0K | N/A |
| Total Liabilities | $465.1M | $436.7M |
| Current Liabilities | $120.1M | $103.5M |
| Short-term Debt | $343.9M | $343.7M |
| Total Debt | $343.9M† | $343.7M† |
| Shareholders' Equity | $64.6M | $288.1M |
| Retained Earnings | -$1.51B | -$1.22B |
† Total Debt: Derived from short-term debt only (no total or long-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$323.0M | -$274.9M |
| CapEx | $187.0K | N/A |
| Investing Cash Flow | $290.0M | -$219.8M |
| Financing Cash Flow | $13.7M | $353.4M |
| Net Change in Cash | -$19.3M | -$141.3M |
| Free Cash Flow | -$323.2M | -$274.9M |
FAQ
What is SNDX P/E and revenue?
Syndax Pharmaceuticals Inc (SNDX) rev $172.4M.
What is SNDX revenue?
Syndax Pharmaceuticals Inc last cached revenue is $172.4M (FY2025).
Is SNDX profitable?
Syndax Pharmaceuticals Inc last cached net income is -$285.4M (FY2025).
What are SNDX total assets?
Syndax Pharmaceuticals Inc last cached total assets are $529.7M (FY2025).
What is SNDX free cash flow?
Syndax Pharmaceuticals Inc last cached free cash flow is -$323.2M (FY2025).
Not investment advice. Cached statements, not a live tape.